Document:

Warrant to Purchase Common Stock

 Exhibit 10.10 
  
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR
INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO
THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933. 

  

	 Warrant No. CW-57
	 	Number of Shares: 35,000
	 Date of Issuance: April 1, 2003
	 	(subject to adjustment)

  
 XCYTE THERAPIES,
INC. 
  
 Common Stock Purchase Warrant

  
 Xcyte Therapies, Inc., a Delaware corporation (the
“Company”), for value received, hereby certifies that Inkeun Lee, or its registered assigns (the “Registered Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at any time
after the date hereof and on or before the Expiration Date (as defined in Section 5 below), up to 35,000 shares of Common Stock of the Company, at a purchase price of $1.00 per share. The shares purchasable upon exercise of this Warrant and the
purchase price per share, as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Stock” and the “Purchase Price,” respectively. 
  
 This Warrant is issued pursuant to, and is subject to the terms and
conditions of, the Consulting Agreement dated April 1, 2003 among the Company and Ike Lee (the “Purchase Agreement”). 
  
 1.    Exercise. 
  
 (a)    Manner of Exercise.    This Warrant shall vest and become exercisable as follows:
1/7th of the total number of shares shall vest on April 1,2003, and 1/7th of the total number of shares shall vest monthly thereafter (total vesting in 7 months). The vested shares under this Warrant may be exercised by the
Registered Holder, in whole or in part, by surrendering this Warrant, with the purchase/exercise form appended hereto as Exhibit A duly executed by such Registered Holder or by such Registered Holder’s duly authorized attorney, at the
principal office of the Company, or at such other office or agency as the Company may designate, accompanied by payment in full of the Purchase Price payable in respect of the number of shares of Warrant Stock purchased upon such exercise. The
Purchase Price may be paid by cash, check, wire transfer or by the surrender of promissory notes or other instruments representing indebtedness of the Company to the Registered Holder. 
  
 (b)    Effective Time of Exercise.    Each exercise of this Warrant
shall be deemed to have been effected immediately prior to the close of business on the day on which this 

 Warrant shall have been surrendered to the Company as provided in Section 1(a) above. At such time, the person or persons
in whose name or names any certificates for Warrant Stock shall be issuable upon such exercise as provided in Section 1(d) below shall be deemed to have become the holder or holders of record of the Warrant Stock represented by such certificates.

  
 (c)    Net Issue Exercise.

  
 (i)    In lieu of exercising this Warrant
in the manner provided above in Section 1(a), the Registered Holder may elect to receive shares equal to the value of this Warrant (or the portion thereof being canceled) by surrender of this Warrant at the principal office of the Company together
with notice of such election on the purchase/exercise form appended hereto as Exhibit A duly executed by such Registered Holder or such Registered Holder’s duly authorized attorney, in which event the Company shall issue to such Holder a
number of shares of Warrant Stock computed using the following formula: 
  
 X = Y (A—B) 
       A 
  

	Where X  =	The number of shares of Warrant Stock to be issued to the Registered Holder. 

  

	 	Y  =	The number of shares of Warrant Stock purchasable under this Warrant (at the date of such calculation). 

  

	 	A  =	The fair market value of one share of Warrant Stock (at the date of such calculation). 

  

	 	B  =	The Purchase Price (as adjusted to the date of such calculation). 

  
 (ii)    For purposes of this Section 1(c), the fair market value of Warrant Stock on the date of calculation shall mean with respect
to each share of Warrant Stock: 
  
 (A)    if the exercise is in connection with an initial public offering of the Company’s Common Stock, and if the Company’s Registration Statement relating to such public offering has been declared effective by
the Securities and Exchange Commission, then the fair market value per share shall be the product of (x) the initial “Price to Public” specified in the final prospectus with respect to the offering and (y) the number of shares of Common
Stock into which each share of Warrant Stock is convertible at the date of calculation; 
  
 (B)    if (A) is not applicable, the fair market value of Warrant Stock shall be at the highest price per share which
the Company could obtain on the date of calculation from a willing buyer (not a current employee or director) for shares of Warrant Stock sold by the Company, from authorized but unissued shares, as determined in good faith by the Board of
Directors, unless the Company is at such time subject to an acquisition as described in Section 5(b) below, in which case the fair market value of Warrant Stock shall be deemed to be the value received by the holders of such stock pursuant to such
acquisition. 
  
 (d)    Delivery to
Holder.    As soon as practicable after the exercise of this Warrant in whole or in part, and in any event within ten (10) days thereafter, the Company at its 
  

 2 

 expense will cause to be issued in the name of, and delivered to, the Registered Holder, or as such Holder (upon payment
by such Holder of any applicable transfer taxes) may direct: 
  
 (i)    a certificate or certificates for the number of shares of Warrant Stock to which such Registered Holder shall be entitled, and 
  
 (ii)    in case such exercise is in part only, a new warrant or warrants (dated the date
hereof) of like tenor, calling in the aggregate on the face or faces thereof for the number of shares of Warrant Stock equal (without giving effect to any adjustment therein) to the number of such shares called for on the face of this Warrant minus
the number of such shares purchased by the Registered Holder upon such exercise as provided in Section 1(a) or 1(c) above. 
  
 2.    Adjustments. 
  
 (a)    Stock Splits and Dividends.    If outstanding shares of the Company’s Common Stock shall
be subdivided into a greater number of shares or a dividend in Common Stock shall be paid in respect of Common Stock, the Purchase Price in effect immediately prior to such subdivision or at the record date of such dividend shall simultaneously with
the effectiveness of such subdivision or immediately after the record date of such dividend be proportionately reduced. If outstanding shares of Common Stock shall be combined into a smaller number of shares, the Purchase Price in effect immediately
prior to such combination shall, simultaneously with the effectiveness of such combination, be proportionately increased. When any adjustment is required to be made in the Purchase Price, the number of shares of Warrant Stock purchasable upon the
exercise of this Warrant shall be changed to the number determined by dividing (i) an amount equal to the number of shares issuable upon the exercise of this Warrant immediately prior to such adjustment, multiplied by the Purchase Price in effect
immediately prior to such adjustment, by (ii) the Purchase Price in effect immediately after such adjustment. 
  
 (b)    Reclassification, Etc.    In case there occurs any reclassification or change of the
outstanding securities of the Company or of any reorganization of the Company (or any other corporation the stock or securities of which are at the time receivable upon the exercise of this Warrant) or any similar corporate reorganization on or
after the date hereof, then and in each such case the Registered Holder, upon the exercise hereof at any time after the consummation of such reclassification, change, or reorganization shall be entitled to receive, in lieu of the stock or
other securities and property receivable upon the exercise hereof prior to such consummation, the stock or other securities or property to which such Holder would have been entitled upon such consummation if such Holder had exercised this Warrant
immediately prior thereto, all subject to further adjustment pursuant to the provisions of this Section 2. 
  
 (c)    Adjustment Certificate.    When any adjustment is required to be made in the Warrant Stock or
the Purchase Price pursuant to this Section 2, the Company shall promptly mail to the Registered Holder a certificate setting forth (i) a brief statement of the facts requiring such adjustment, (ii) the Purchase Price after such adjustment and (iii)
the kind and amount of stock or other securities or property into which this Warrant shall be exercisable after such adjustment. 
  

 3 

 (d)    Acknowledgement.    In order to avoid doubt,
it is acknowledged that the holder of this Warrant shall be entitled to the benefit of all adjustments in the number of shares of Common Stock of the Company. 
  

3.    Transfers. 
  
 (a)    Unregistered Security.    Each holder of this Warrant acknowledges that this Warrant, the
Warrant Stock and the Common Stock of the Company have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), and agrees not to sell, pledge, distribute, offer for sale, transfer or otherwise
dispose of this Warrant, any Warrant Stock issued upon its exercise in the absence of (i) an effective registration statement under the Act as to this Warrant or such Warrant Stock and registration or qualification of this Warrant or such Warrant
Stock under any applicable U.S. federal or state securities law then in effect, or (ii) an opinion of counsel, satisfactory to the Company, that such registration and qualification are not required. Each certificate or other instrument for Warrant
Stock issued upon the exercise of this Warrant shall bear a legend substantially to the foregoing effect. 
  
 (b)    Transferability.    Subject to the provisions of Section 3(a) hereof, this Warrant and all
rights hereunder are transferable, in whole or in part, upon surrender of the Warrant with a properly executed assignment (in the form of Exhibit B hereto) at the principal office of the Company. 
  
 (c)    Warrant
Register.    The Company will maintain a register containing the names and addresses of the Registered Holders of this Warrant. Until any transfer of this Warrant is made in the warrant register, the Company may treat the
Registered Holder of this Warrant as the absolute owner hereof for all purposes; provided, however, that if this Warrant is properly assigned in blank, the Company may (but shall not be required to) treat the bearer hereof as the
absolute owner hereof for all purposes, notwithstanding any notice to the contrary. Any Registered Holder may change such Registered Holder’s address as shown on the warrant register by written notice to the Company requesting such change.

  
 4.    No
Impairment.    The Company will not, by amendment of its charter or through reorganization, consolidation, merger, dissolution, sale of assets or any other voluntary action, avoid or seek to avoid the observance or
performance of any of the terms of this Warrant, but will (subject to Section 13 below) at all times in good faith assist in the carrying out of all such terms and in the taking of all such action as may be necessary or appropriate in order to
protect the rights of the holder of this Warrant against impairment. 
  
 5.    Termination.    This Warrant (and the right to purchase securities upon exercise hereof) shall terminate upon the earliest to occur of the following (the “Expiration
Date”): (a) April 1, 2008, (b) immediately prior to the sale, conveyance or disposal of all or substantially all of the Company’s property or business or the Company’s merger into or consolidation with any other corporation (other
than a wholly-owned subsidiary of the Company) or any other transaction or series of related transactions in which more than fifty percent (50%) of the voting power of the Company is disposed of, provided that this Section 5(b) shall not
apply to a merger effected exclusively for the purpose of changing the domicile of the Company, or (c) immediately prior to the closing of a firm commitment underwritten public offering pursuant 
  

 4 

 to a registration statement on Form S-1 under the Securities Act, the public offering price of which is not less than
$4.00 per share (appropriately adjusted for any stock split, dividend, combination or other recapitalization) and which results in aggregate cash proceeds to the Company of $20,000,000 (net of underwriting discounts and commissions). 
  
 6.    Notices of Certain
Transactions.    In case: 
  
 (a)    the Company shall take a record of the holders of its Common Stock (or other stock or securities at the time deliverable upon the exercise of this Warrant) for the purpose of entitling or enabling them to receive
any dividend or other distribution, or to receive any right to subscribe for or purchase any shares of stock of any class or any other securities, or to receive any other right, to subscribe for or purchase any shares of stock of any class or any
other securities, or to receive any other right, or 
  
 (b)    of any capital reorganization of the Company, any reclassification of the capital stock of the Company, any consolidation or merger of the Company, any consolidation or merger of the Company with or into another
corporation (other than a consolidation or merger in which the Company is the surviving entity), or any transfer of all or substantially all of the assets of the Company, or 
  
 (c)    of the voluntary or involuntary dissolution, liquidation or winding-up of the Company,

  
 then, and in each such case, the Company will mail or cause to be mailed to
the Registered Holder of this Warrant a notice specifying, as the case may be, (i) the date on which a record is to be taken for the purpose of such dividend, distribution or right, and stating the amount and character of such dividend, distribution
or right, or (ii) the effective date on which such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation, winding-up or redemption is to take place, and the time, if any is to be fixed, as of which the holders
of record of Common Stock (or such other stock or securities at the time deliverable upon such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation, winding-up or redemption) are to be determined. Such notice
shall be mailed at least ten (10) days prior to the record date or effective date for the event specified in such notice. 
  
 7.    Reservation of Stock.    The Company will at all times reserve and keep available, solely for
the issuance and delivery upon the exercise of this Warrant, such shares of Warrant Stock and other stock, securities and property, as from time to time shall be issuable upon the exercise of this Warrant. 
  
 8.    Exchange of
Warrants.    Upon the surrender by the Registered Holder of any Warrant or Warrants, properly endorsed, to the Company at the principal office of the Company, the Company will, subject to the provisions of Section 3
hereof, issue and deliver to or upon the order of such Holder, at the Company’s expense, a new Warrant or Warrants of like tenor, in the name of such Registered Holder or as such Registered Holder (upon payment by such Registered Holder of any
applicable transfer taxes) may direct, calling in the aggregate on the face or faces thereof for the number of shares of Common Stock called for on the face or faces of the Warrant or Warrants so surrendered. 
  

 5 

 9.    Replacement of Warrant.    Upon receipt of
evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and (in the case of loss, theft or destruction) upon delivery of an indemnity agreement (with surety if reasonably required) in an amount
reasonably satisfactory to the Company, or (in the case of mutilation) upon surrender and cancellation of this Warrant, the Company will issue, in lieu thereof, a new Warrant of like tenor. 
  
 10.    Mailing of
Notices.    Any notice required or permitted pursuant to this Warrant shall be in writing and shall be deemed sufficient upon receipt, when delivered personally or sent by courier, overnight delivery service or confirmed
facsimile, or forty-eight (48) hours after being deposited in the regular mail, as certified or registered mail (airmail if sent internationally), with postage prepaid, addressed (a) if to the Registered Holder, to the address of the Registered
Holder most recently furnished in writing to the Company and (b) if to the Company, to the address set forth below or subsequently modified by written notice to the Registered Holder. 
  
 11.    No Rights as Stockholder.    Until the exercise of this
Warrant, the Registered Holder of this Warrant shall not have or exercise any rights by virtue hereof as a stockholder of the Company. 
  
 12.    No Fractional Shares.    No fractional shares of Common Stock will be issued in connection
with any exercise hereunder. In lieu of any fractional shares which would otherwise be issuable, the Company shall pay cash equal to the product of such fraction multiplied by the fair market value of one share of Common Stock on the date of
exercise, as determined in good faith by the Company’s Board of Directors. 
  
 13.    Amendment or Waiver.    Any term of this Warrant may be amended or waived upon written consent of the Company and the holder of this warrant. 
  
 14.    Headings.    The
headings in this Warrant are for purposes of reference only and shall not limit or otherwise affect the meaning of any provision of this Warrant. 
  
 15.    Governing Law.    This Warrant shall be governed, construed and interpreted in accordance
with the laws of the State of Washington, without giving effect to principles of conflicts of law. 
  
 16.    Market Standoff Agreement.    The Registered Holder agrees in connection with any
registration of the Company’s securities (other than a registration of debt securities, securities in a Rule 145 transaction or with respect to an employee benefit plan), upon notice by the Company or the underwriters managing any underwritten
public offering of the Company’s securities, not to sell, make any short sale of, loan pledge (or otherwise encumber or hypothecate), grant any option for the purchase of, or otherwise directly or indirectly dispose of this Warrant or any
Warrant Stock without the prior written consent of the Company and such managing underwriters for such period of time as the Board of Directors establishes pursuant to its good faith negotiations with such managing underwriters, which period shall
not exceed 180 days. The Registered Holder hereby consents to the placement of stop transfer orders with the Company’s transfer agent in order to enforce the foregoing provision. 
  

 6 

 17.    Restrictive Legend.    Each certificate
representing (i) the Warrant Stock, and (ii) any other securities issued in respect of the Warrant Stock upon any stock split, stock dividend, recapitalization, merger, consolation or similar event, shall be stamped or otherwise imprinted with
legends in the following form (in addition to any legend required under applicable state securities laws): 
  
 “THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE
“SECURITIES ACT”). SUCH SHARES MAY NOT BE SOLD, TRANSFERRED OR PLEDGED IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS THE COMPANY RECEIVES AN OPINION OF COUNSEL (WHICH MAY BE STATING THAT SUCH SALE OR TRANSFER IS EXEMPT FROM THE
REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE SECURITIES ACT.” 
  
 “THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A MARKET STAND-OFF AGREEMENT IN THE EVENT OF A PUBLIC OFFERING, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY.” 
  

	XCYTE THERAPIES, INC.
		
	By:	 	 
	 	

	 	 	Ronald J. Berenson, President
	
	 Address:       1124 Columbia Street
 Suite 130
 Seattle, Washington
98104
  
 Fax Number: (206) 262-0900

  

 7 

 EXHIBIT A 
  

PURCHASE/EXERCISE FORM 
  

	To:    Xcyte Therapies, Inc.	 	Dated:                                     
   

  
 The undersigned,
pursuant to the provisions set forth in the attached Warrant No. CW-57, hereby irrevocably elects to (a) purchase              shares of the Common Stock covered by such Warrant and
herewith makes payment of $            , representing the full purchase price for such shares at the price per share provided for in such Warrant, or (b) exercise such Warrant for
             shares purchasable under the Warrant pursuant to the Net Issue Exercise provisions of Section 1(c) of such Warrant. 
  
 The undersigned acknowledges that it has reviewed the representations and
warranties contained in Section 3(a) of the Warrant and by its signature below hereby makes such representations and warranties to the Company. 
  
 The undersigned further acknowledges that it has reviewed the market standoff provisions set forth in Section 16 of the Warrant and agrees to be bound by
such provisions. 
  
 Signature:                                   
                                        
         
  
 Name
(print):                                      
                                        

 
 Title (if
applic.)                                     
                                    
  
 Company (if
applic.):                                      
                         

 EXHIBIT B 
  

ASSIGNMENT FORM 
  
 FOR VALUE RECEIVED,
                                        
             hereby sells, assigns and transfers all of the rights of the undersigned under the attached Warrant with respect to the number of shares of Common Stock covered thereby set
forth below, unto: 
  

	Name of Assignee	 	Address/Fax Number	 	No. of Shares

  
  
  

	Dated:                                	 	Signature:	 	 
	 	 	 	

			
	 	 	 	 	 
	 	 	 	

			
	 	 	Witness:Warrant to Purchase Common Stock

 Exhibit 10.11 
  
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR
INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO
THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933. 
  

  

	 Warrant No. CW-58
	  	Number of Shares: 40,000
	 Date of Issuance: April 1, 2003
	  	(subject to adjustment)

  
 XCYTE THERAPIES,
INC. 
  
 Common Stock Purchase Warrant

  
 Xcyte Therapies, Inc., a Delaware corporation (the
“Company”), for value received, hereby certifies that Inkeun Lee, or its registered assigns (the “Registered Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at any time
after the date hereof and on or before the Expiration Date (as defined in Section 5 below), up to 40,000 shares of Common Stock of the Company, at a purchase price of $1.00 per share. The shares purchasable upon exercise of this Warrant and the
purchase price per share, as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Stock” and the “Purchase Price,” respectively. 
  
 This Warrant is issued pursuant to, and is subject to the terms and
conditions of, the Consulting Agreement dated April 1, 2003 among the Company and Ike Lee (the “Purchase Agreement”). 
  
 1.    Exercise. 
  
 (a)     Manner of Exercise. This Warrant shall vest and become exercisable as follows: 50% of the total
number of shares shall vest upon the Company’s execution of a letter of intent to enter into an Alliance Agreement (as defined in the Consulting Agreement) with a Potential Partner (as defined in the Consulting Agreement) and the remaining
shares shall vest upon the Company’s execution of an Alliance Agreement with a Potential Partner. The vested shares under this Warrant may be exercised by the Registered Holder, in whole or in part, by surrendering this Warrant, with the
purchase/exercise form appended hereto as Exhibit A duly executed by such Registered Holder or by such Registered Holder’s duly authorized attorney, at the principal office of the Company, or at such other office or agency as the Company
may designate, accompanied by payment in full of the Purchase Price payable in respect of the number of shares of Warrant Stock purchased upon such exercise. The Purchase Price may be paid by cash, check, wire transfer or by the surrender of
promissory notes or other instruments representing indebtedness of the Company to the Registered Holder. 

 (b)    Effective Time of Exercise. Each exercise of this Warrant shall
be deemed to have been effected immediately prior to the close of business on the day on which this Warrant shall have been surrendered to the Company as provided in Section 1(a) above. At such time, the person or persons in whose name or names any
certificates for Warrant Stock shall be issuable upon such exercise as provided in Section 1(d) below shall be deemed to have become the holder or holders of record of the Warrant Stock represented by such certificates. 
  
 (c)    Net Issue Exercise. 
  
 (i)    In lieu of exercising this Warrant
in the manner provided above in Section 1(a), the Registered Holder may elect to receive shares equal to the value of this Warrant (or the portion thereof being canceled) by surrender of this Warrant at the principal office of the Company together
with notice of such election on the purchase/exercise form appended hereto as Exhibit A duly executed by such Registered Holder or such Registered Holder’s duly authorized attorney, in which event the Company shall issue to such Holder a
number of shares of Warrant Stock computed using the following formula: 
  
 X = Y (A - B) 
 A 
  
 Where         X = The number of shares of Warrant Stock to be issued to the Registered Holder. 
  
                     Y = The number of shares of Warrant Stock purchasable under this Warrant (at the date of such calculation). 

 
                     A = The fair market value of one share of Warrant Stock (at the date of such calculation). 
  
                     B = The Purchase Price (as adjusted to the date of such calculation). 
  
 (ii)     For purposes of this Section
1(c), the fair market value of Warrant Stock on the date of calculation shall mean with respect to each share of Warrant Stock: 
  
 (A)    if the exercise is in connection with an initial public offering of the Company’s Common Stock, and if the
Company’s Registration Statement relating to such public offering has been declared effective by the Securities and Exchange Commission, then the fair market value per share shall be the product of (x) the initial “Price to Public”
specified in the final prospectus with respect to the offering and (y) the number of shares of Common Stock into which each share of Warrant Stock is convertible at the date of calculation; 
  
 (B)    if (A) is not applicable, the
fair market value of Warrant Stock shall be at the highest price per share which the Company could obtain on the date of calculation from a willing buyer (not a current employee or director) for shares of Warrant Stock sold by the Company, from
authorized but unissued shares, as determined in good faith by the Board of Directors, unless the Company is at such time subject to an acquisition as described in Section 5(b) below, in which case the fair market value of Warrant Stock shall be
deemed to be the value received by the holders of such stock pursuant to such acquisition. 
  

 2 

 (d)    Delivery to Holder.    As soon as
practicable after the exercise of this Warrant in whole or in part, and in any event within ten (10) days thereafter, the Company at its expense will cause to be issued in the name of, and delivered to, the Registered Holder, or as such Holder (upon
payment by such Holder of any applicable transfer taxes) may direct: 
  
 (i)    a certificate or certificates for the number of shares of Warrant Stock to which such Registered Holder shall be entitled, and 
  
 (ii)    in case such exercise is in part only, a new warrant or warrants (dated the date
hereof) of like tenor, calling in the aggregate on the face or faces thereof for the number of shares of Warrant Stock equal (without giving effect to any adjustment therein) to the number of such shares called for on the face of this Warrant minus
the number of such shares purchased by the Registered Holder upon such exercise as provided in Section 1(a) or 1(c) above. 
  
 2.    Adjustments. 
  
 (a)    Stock Splits and Dividends.    If outstanding shares of the Company’s Common Stock shall
be subdivided into a greater number of shares or a dividend in Common Stock shall be paid in respect of Common Stock, the Purchase Price in effect immediately prior to such subdivision or at the record date of such dividend shall simultaneously with
the effectiveness of such subdivision or immediately after the record date of such dividend be proportionately reduced. If outstanding shares of Common Stock shall be combined into a smaller number of shares, the Purchase Price in effect immediately
prior to such combination shall, simultaneously with the effectiveness of such combination, be proportionately increased. When any adjustment is required to be made in the Purchase Price, the number of shares of Warrant Stock purchasable upon the
exercise of this Warrant shall be changed to the number determined by dividing (i) an amount equal to the number of shares issuable upon the exercise of this Warrant immediately prior to such adjustment, multiplied by the Purchase Price in effect
immediately prior to such adjustment, by (ii) the Purchase Price in effect immediately after such adjustment. 
  
 (b)    Reclassification, Etc.    In case there occurs any
reclassification or change of the outstanding securities of the Company or of any reorganization of the Company (or any other corporation the stock or securities of which are at the time receivable upon the exercise of this Warrant) or any similar
corporate reorganization on or after the date hereof, then and in each such case the Registered Holder, upon the exercise hereof at any time after the consummation of such reclassification, change, or reorganization shall be entitled to
receive, in lieu of the stock or other securities and property receivable upon the exercise hereof prior to such consummation, the stock or other securities or property to which such Holder would have been entitled upon such consummation if such
Holder had exercised this Warrant immediately prior thereto, all subject to further adjustment pursuant to the provisions of this Section 2. 
  
 (c)    Adjustment Certificate.    When any adjustment is required to be made in the Warrant Stock or
the Purchase Price pursuant to this Section 2, the Company shall promptly mail to the Registered Holder a certificate setting forth (i) a brief statement of the facts requiring such adjustment, (ii) the Purchase Price after such adjustment and (iii)
the kind and amount of 
  

 3 

 stock or other securities or property into which this Warrant shall be exercisable after such adjustment. 
  
 (d)    Acknowledgement.    In order to avoid doubt, it is acknowledged that the holder of this Warrant shall be entitled to the benefit of all adjustments in the number of shares of
Common Stock of the Company. 
  
 3.    Transfers. 
  
 (a)    Unregistered Security.    Each holder of this Warrant acknowledges that this Warrant, the Warrant Stock and the Common Stock of the Company have not been registered under the
Securities Act of 1933, as amended (the “Securities Act”), and agrees not to sell, pledge, distribute, offer for sale, transfer or otherwise dispose of this Warrant, any Warrant Stock issued upon its exercise in the absence of (i)
an effective registration statement under the Act as to this Warrant or such Warrant Stock and registration or qualification of this Warrant or such Warrant Stock under any applicable U.S. federal or state securities law then in effect, or (ii) an
opinion of counsel, satisfactory to the Company, that such registration and qualification are not required. Each certificate or other instrument for Warrant Stock issued upon the exercise of this Warrant shall bear a legend substantially to the
foregoing effect. 
  
 (b)    Transferability.    Subject to the provisions of Section 3(a), this Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of the Warrant with a
properly executed assignment (in the form of Exhibit B hereto) at the principal office of the Company. 
  
 (c)    Warrant Register.    The Company will maintain a register containing the names and addresses
of the Registered Holders of this Warrant. Until any transfer of this Warrant is made in the warrant register, the Company may treat the Registered Holder of this Warrant as the absolute owner hereof for all purposes; provided,
however, that if this Warrant is properly assigned in blank, the Company may (but shall not be required to) treat the bearer hereof as the absolute owner hereof for all purposes, notwithstanding any notice to the contrary. Any Registered
Holder may change such Registered Holder’s address as shown on the warrant register by written notice to the Company requesting such change. 
  
 4.    No Impairment.    The Company will not, by amendment of its charter or through reorganization,
consolidation, merger, dissolution, sale of assets or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will (subject to Section 13 below) at all times in good faith assist in
the carrying out of all such terms and in the taking of all such action as may be necessary or appropriate in order to protect the rights of the holder of this Warrant against impairment. 
  
 5.    Termination.    This Warrant (and
the right to purchase securities upon exercise hereof) shall terminate upon the earliest to occur of the following (the “Expiration Date”): (a) April 1, 2008, (b) immediately prior to the sale, conveyance or disposal of all or
substantially all of the Company’s property or business or the Company’s merger into or consolidation with any other corporation (other than a wholly-owned subsidiary of the Company) or any other transaction or series of related
transactions in which more than fifty percent (50%) of the voting 
  

 4 

 power of the Company is disposed of, provided that this Section 5(b) shall not apply to a merger effected
exclusively for the purpose of changing the domicile of the Company, or (c) immediately prior to the closing of a firm commitment underwritten public offering pursuant to a registration statement on Form S-1 under the Securities Act, the public
offering price of which is not less than $4.00 per share (appropriately adjusted for any stock split, dividend, combination or other recapitalization) and which results in aggregate cash proceeds to the Company of $20,000,000 (net of underwriting
discounts and commissions). 
  
 6.    Notices of Certain Transactions.    In case: 
  
 (a)    the Company shall take a record of the holders of its Common Stock (or other stock or securities at the time deliverable upon
the exercise of this Warrant) for the purpose of entitling or enabling them to receive any dividend or other distribution, or to receive any right to subscribe for or purchase any shares of stock of any class or any other securities, or to receive
any other right, to subscribe for or purchase any shares of stock of any class or any other securities, or to receive any other right, or 
  
 (b)    of any capital reorganization of the Company, any reclassification of the capital stock of the Company, any consolidation or
merger of the Company, any consolidation or merger of the Company with or into another corporation (other than a consolidation or merger in which the Company is the surviving entity), or any transfer of all or substantially all of the assets of the
Company, or 
  
 (c)    of the voluntary or
involuntary dissolution, liquidation or winding-up of the Company, 
  
 then, and
in each such case, the Company will mail or cause to be mailed to the Registered Holder of this Warrant a notice specifying, as the case may be, (i) the date on which a record is to be taken for the purpose of such dividend, distribution or right,
and stating the amount and character of such dividend, distribution or right, or (ii) the effective date on which such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation, winding-up or redemption is to take
place, and the time, if any is to be fixed, as of which the holders of record of Common Stock (or such other stock or securities at the time deliverable upon such reorganization, reclassification, consolidation, merger, transfer, dissolution,
liquidation, winding-up or redemption) are to be determined. Such notice shall be mailed at least ten (10) days prior to the record date or effective date for the event specified in such notice. 
  
 7.    Reservation of
Stock.    The Company will at all times reserve and keep available, solely for the issuance and delivery upon the exercise of this Warrant, such shares of Warrant Stock and other stock, securities and property, as from
time to time shall be issuable upon the exercise of this Warrant. 
  
 8.    Exchange of Warrants.    Upon the surrender by the Registered Holder of any Warrant or Warrants, properly endorsed, to the Company at the principal office of the Company, the
Company will, subject to the provisions of Section 3 hereof, issue and deliver to or upon the order of such Holder, at the Company’s expense, a new Warrant or Warrants of like tenor, in the name of such Registered Holder or as such Registered

  

 5 

 Holder (upon payment by such Registered Holder of any applicable transfer taxes) may direct, calling in the aggregate on
the face or faces thereof for the number of shares of Common Stock called for on the face or faces of the Warrant or Warrants so surrendered. 
  
 9.    Replacement of Warrants.    Upon receipt of evidence reasonably satisfactory to the Company of
the loss, theft, destruction or mutilation of this Warrant and (in the case of loss, theft or destruction) upon delivery of an indemnity agreement (with surety if reasonably required) in an amount reasonably satisfactory to the Company, or (in the
case of mutilation) upon surrender and cancellation of this Warrant, the Company will issue, in lieu thereof, a new Warrant of like tenor. 
  
 10.    Mailing of Notices.    Any notice required or permitted pursuant to this Warrant shall be in
writing and shall be deemed sufficient upon receipt, when delivered personally or sent by courier, overnight delivery service or confirmed facsimile, or forty-eight (48) hours after being deposited in the regular mail, as certified or registered
mail (airmail if sent internationally), with postage prepaid, addressed (a) if to the Registered Holder, to the address of the Registered Holder most recently furnished in writing to the Company and (b) if to the Company, to the address set forth
below or subsequently modified by written notice to the Registered Holder. 
  
 11.    No Rights as Stockholder.    Until the exercise of this Warrant, the Registered Holder of this Warrant shall not have or exercise any rights by virtue
hereof as a stockholder of the Company. 
  
 12.    No Fractional Shares.    No fractional shares of Common Stock will be issued in connection with any exercise hereunder. In lieu of any fractional shares which would otherwise be
issuable, the Company shall pay cash equal to the product of such fraction multiplied by the fair market value of one share of Common Stock on the date of exercise, as determined in good faith by the Company’s Board of Directors.

  
 13.    Amendment or
Waiver.    Any term of this Warrant may be amended or waived upon written consent of the Company and the holder of this warrant. 
  
 14.    Headings.    The headings in this Warrant are for purposes of reference only and shall not
limit or otherwise affect the meaning of any provision of this Warrant. 
  
 15.    Governing Law.    This Warrant shall be governed, construed and interpreted in accordance with the laws of the State of Washington, without giving effect to principles of
conflicts of law. 
  
 16.    Market
Standoff Agreement.    The Registered Holder agrees in connection with any registration of the Company’s securities (other than a registration of debt securities, securities in a Rule 145 transaction or with respect
to an employee benefit plan), upon notice by the Company or the underwriters managing any underwritten public offering of the Company’s securities, not to sell, make any short sale of, loan pledge (or otherwise encumber or hypothecate), grant
any option for the purchase of, or otherwise directly or indirectly dispose of this Warrant or any Warrant Stock without the prior written consent of the Company and such managing underwriters for such period of time as the Board of Directors
establishes pursuant to 
  

 6 

 its good faith negotiations with such managing underwriters, which period shall not exceed 180 days. The Registered
Holder hereby consents to the placement of stop transfer orders with the Company’s transfer agent in order to enforce the foregoing provision. 
  
 17.    Restrictive Legend.    Each certificate representing (i) the Warrant Stock, and (ii) any
other securities issued in respect of the Warrant Stock upon any stock split, stock dividend, recapitalization, merger, consolation or similar event, shall be stamped or otherwise imprinted with legends in the following form (in addition to any
legend required under applicable state securities laws): 
  
 “THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT FO 1933 (THE “SECURITIES ACT”). SUCH SHARES MAY NOT BE SOLD, TRANSFERRED OR PLEDGED IN THE
ABSENCE OF SUCH REGISTRATION OR UNLESS THE COMPANY RECIEVES AN OPINION OF COUNSEL (WHICH MAY BE STATING THAT SUCH SALE OR TRANSFER IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE SECURITIES ACT.” 
  
 “THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A MARKET
STAND-OFF AGREEMENT IN THE EVENT OF A PUBLIC OFFERING, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY.” 
  

	XCYTE THERAPIES, INC.
		
	 By:
	 	 
	 	

	 	 	Ronald J. Berenson, President

  

	 Address:
	 	1124 Columbia Street
	 	 	Suite 130
	 	 	Seattle, Washington 98104
		
	 Fax Number:
	 	(206) 262-0900

  
  

 7 

 EXHIBIT A 
  

PURCHASE/EXERCISE FORM 
  
 To:    Xcyte Therapies, Inc. 
 Dated:                          
  
 The undersigned, pursuant to the provisions set forth in the attached Warrant
No. CW-58, hereby irrevocably elects to (a) purchase              shares of the Common Stock covered by such Warrant and herewith makes payment of
$            , representing the full purchase price for such shares at the price per share provided for in such Warrant, or (b) exercise such Warrant for
             shares purchasable under the Warrant pursuant to the Net Issue Exercise provisions of Section 1(c) of such Warrant. 
  
 The undersigned acknowledges that it has reviewed the representations and
warranties contained in Section 3(a) of the Warrant and by its signature below hereby makes such representations and warranties to the Company. 
  
 The undersigned further acknowledges that it has reviewed the market standoff provisions set forth in Section 16 of Warrant and agrees to be bound by such
provisions. 
  

	 Signature:
	 	 
	 	

	 Name (print):
	 	 
	 	

	 Title (if applic.)
	 	 
	 	

	 Company (if applic.):
	 	 
	 	

 EXHIBIT B 
  

ASSIGNMENT FORM 
  
 FOR VALUE RECEIVED,
                                        
         hereby sells, assigns and transfers all of the rights of the undersigned under the attached Warrant with respect to the number of shares of Common Stock covered thereby set forth below, unto:

  

	 Name of Assignee

	 	 Address/Fax Number

	 	 No. of Shares

  

	Dated:                                	 	Signature:	 	 
	 	 	 	

			
	 	 	 	 	 
	 	 	 	

			
	 	 	Witness:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}]]